The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Gout-associated uric acid crystals activate the NALP3 inflammasome
Abstract
Development of the acute and chronic inflammatory responses known as gout and pseudogout are associated with the deposition of monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals, respectively, in joints and periarticular tissues. Although MSU crystals were first identified as the aetiological agent of gout in the eighteenth century and more recently as a 'danger signal' released from dying cells, little is known about the molecular mechanisms underlying MSU- or CPPD-induced inflammation. Here we show that MSU and CPPD engage the caspase-1-activating NALP3 (also called cryopyrin) inflammasome, resulting in the production of active interleukin (IL)-1beta and IL-18. Macrophages from mice deficient in various components of the inflammasome such as caspase-1, ASC and NALP3 are defective in crystal-induced IL-1beta activation. Moreover, an impaired neutrophil influx is found in an in vivo model of crystal-induced peritonitis in inflammasome-deficient mice or mice deficient in the IL-1beta receptor (IL-1R). These findings provide insight into the molecular processes underlying the inflammatory conditions of gout and pseudogout, and further support a pivotal role of the inflammasome in several autoinflammatory diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Colchicine impairs neutrophil adhesion to vascular endothelium and degranulation and blocks activation of the NLRP3 (NOD-, LRR-, and pyrin domaincontaining protein 3) inflammasome, which is required for cleaving caspase-1 leading to the production of IL-1 β and IL-18. 134-136”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [135]
In the citing paper
“Nucleotide products such as uric acid can also function as DAMPs, presumably by activating the inflammasome in APC, thereby stimulating the production of inflammatory cytokines such as interleukin-1β (IL-1β), IL-18 and IL-33, the secretion of which depends on the inflammasome-mediated activation of caspase-145,46.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [46]
In the citing paper
“The secretion of mature IL-1β induced by asbestos was comparable to amounts observed with monosodium urate crystals (MSU), a known potent activator of IL-1β processing (7) (Fig. 1, A and B).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [7]
In the citing paper
“In addition to PAMPs, Nalp3 has the extraordinary capacity of sensing endogenous stress-associated danger signals (DAMPs) such as ATP (9) or MSU (7).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [7]
In the citing paper
“The Nalp3 inflammasome is implicated in the pathological increase of IL-1β production in autoinflammatory syndromes, such as Muckle-Wells syndrome (22), as well as inflammatory processes, such as gout and pseudogout (7).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [7]
In the citing paper
“The NLRP3 inflammasome senses crystalline danger signals that can occur during autoinflammatory diseases, such as gout or atherosclerosis, and environmental diseases, such as silicosis or asbestosis (18, 20, 22).”
From Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages (2018) · cites this paper as [18]
In the citing paper
“Inhalation of crystalline silica can induce inflammation by stimulating the NLRP3 inflammasome, a cytosolic receptor complex that plays a critical role in driving inflammatory immune responses.”
From Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages (2018) · cites this paper as [18]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [55]
In the citing paper
“Urate and cholesterol crystals, as well as sterile particulates, for example, can bypass the requirement for ATP and P2RX7 for IL-1β production55,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [55]
In the citing paper
“Consistently, in mouse models of sterile injury, such as gout, asbestosis and silicosis, NLRP3-deficient mice exhibited decreased inflammation with reduced levels of tissue infiltration by neutrophils or macrophages55,57,58.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [55]
In the citing paper
“The inflammasome is a multimolecular cytosolic sensor that detects pathogenic microorganisms and sterile stressors and activates caspase-1 during the process of pyroptosis, which, in turn, causes the inactive precursor forms of interleukin-1β and interleukin-18 to become the active forms.”
From Cytokine storm (2020) · cites this paper as [41]
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationThe Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. L., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,864
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,679
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 957
Self-citationNALPs: a novel protein family involved in inflammation
Tschopp, J., Martinon, F., & Burns, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1019 · Cited by 739
Self-citationNLRs join TLRs as innate sensors of pathogens
Martinon, F., & Tschopp, J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.004 · Cited by 673
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,030
Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease
Pennisi, M., Crupi, R., Di Paola, R., Ontario, M. L., Bella, R., Calabrese, E. J., Crea, R., Cuzzocrea, S., & Calabrese, V. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23986 · Cited by 157
Engagement of CD14 Mediates the Inflammatory Potential of Monosodium Urate Crystals
Scott, P., Ma, H., Viriyakosol, S., Terkeltaub, R. A., & Liu‐Bryan, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6370 · Cited by 157
Danger‐associated molecular patterns ( DAMPs ) in acute lung injury
Tolle, L. B., & Standiford, T. J. (2013) · The Journal of Pathology · doi:10.1002/path.4124 · Cited by 157
Kerur, N., Hirano, Y., Tarallo, V., Fowler, B. J., Bastos-Carvalho, A., Yasuma, T. R., Yasuma, R., Kim, Y., Hinton, D. R., Kirschning, C. J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12500 · Cited by 163
Bracey, N. A., Gershkovich, B., Chun, J., Vilaysane, A., Meijndert, H. C., Wright, J. R., Fedak, P. W. M., Beck, P. L., Muruve, D. A., & Duff, H. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550624 · Cited by 156
Monosodium urate crystals in inflammation and immunity
Shi, Y., Mucsi, A. D., & Ng, G. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00851.x · Cited by 163
Synovial mast cells: role in acute and chronic arthritis
Nigrovic, P. A., & Lee, D. M. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00506.x · Cited by 157
Activation of the NLRP3 Inflammasome by Group B Streptococci
Costa, A., Gupta, R., Signorino, G., Malara, A., Cardile, F., Biondo, C., Midiri, A., Galbo, R., Trieu‐Cuot, P., Papasergi, S., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102543 · Cited by 162
He, X., Mekasha, S., Mavrogiorgos, N. C., Fitzgerald, K. A., Lien, E., & Ingalls, R. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903937 · Cited by 160
Inflammasomes: Threat-Assessment Organelles of the Innate Immune System
Evavold, C. L., & Kagan, J. C. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.005 · Cited by 159
ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation
Zheng, S., Que, X., Wang, S., Zhou, Q., Xing, X., Liang, C., Hou, C., Ma, J., An, P., Peng, Y., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.015 · Cited by 165
Hyperuricaemia and gout: time for a new staging system?
Dalbeth, N., & Stamp, L. K. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205304 · Cited by 155
Deregulated inflammasome signaling in disease
Lamkanfi, M., Walle, L. V., & Kanneganti, T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01042.x · Cited by 154
The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
Chen, R., Yin, C., Fang, J., & Liu, B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02131-0 · Cited by 158
Curcumin suppresses NLRP3 inflammasome activation and protects against LPS‐induced septic shock
Gong, Z., Zhou, J., Li, H., Gao, Y., Xu, C., Zhao, S., Chen, Y., Cai, W., & Wu, J. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500316 · Cited by 154
Dalbeth, N., Smith, T., Nicolson, B., Clark, B., Callon, K. E., Naot, D., Haskard, D. O., McQueen, F. M., Reid, I. R., & Cornish, J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23488 · Cited by 157
The role of tissue resident cells in neutrophil recruitment
Kim, N. D., & Luster, A. D. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.07.007 · Cited by 161
The microbial and danger signals that activate Nod-like receptors
Benkő, S., Philpott, D. J., & Girardin, S. E. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.013 · Cited by 156
Morishige, T., Yoshioka, Y., Inakura, H., Tanabe, A., Yao, X., Narimatsu, S., Monobe, Y., Imazawa, T., Tsunoda, S., Tsutsumi, Y. M., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.036 · Cited by 155
Inflammasome-IL-1-Th17 response in allergic lung inflammation
Besnard, A., Togbe, D., Couillin, I., Tan, Z., Zheng, S. G., Erard, F., Bert, M. L., Quesniaux, V. F. J., & Ryffel, B. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr042 · Cited by 155
Tailoring inorganic nanoadjuvants towards next-generation vaccines
Li, X., Wang, X., & Ito, A. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00028j · Cited by 153
TIR, CARD and PYRIN: three domains for an antimicrobial triad
Werts, C., Girardin, S. E., & Philpott, D. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401890 · Cited by 156
Francesco, P. N. D., Mucci, J. M., Ceci, R., Fossati, C. A., & Rozenfeld, P. A. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.02.003 · Cited by 152
Treating to target: a strategy to cure gout
Pérez-Ruiz, F. (2009) · Rheumatology · doi:10.1093/rheumatology/kep087 · Cited by 154
Bauer, C. A., Duewell, P., Lehr, H., Endres, S., & Schnurr, M. M. (2012) · Digestive Diseases · doi:10.1159/000341681 · Cited by 152
Stress molecules in sepsis and systemic inflammatory response syndrome
Adib‐Conquy, M., & Cavaillon, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.074 · Cited by 152
Differential roles of caspase-1 and caspase-11 in infection and inflammation
Man, S. M., Karki, R., Briard, B., Burton, A. R., Gingras, S., Pelletier, S. W., & Kanneganti, T. (2017) · Scientific Reports · doi:10.1038/srep45126 · Cited by 155
Komada, T., Chung, H., Lau, A. N., Platnich, J. M., Beck, P. L., Benediktsson, H., Duff, H. J., Jenne, C. N., & Muruve, D. A. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017080863 · Cited by 152
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
Schwaid, A. G., & Spencer, K. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01307 · Cited by 154
Tapia‐Abellán, A., Angosto-Bazarra, D., Alarcón‐Vila, C., Baños, M. C., Hafner‐Bratkovič, I., Oliva, B., & Pelegrín, P. (2021) · Science Advances · doi:10.1126/sciadv.abf4468 · Cited by 155
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review
Zhang, F.-S., He, Q.-Z., Qin, C. X., Little, P. J., Weng, J., & Xu, S. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00835-w · Cited by 156
Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury
Leaf, I. A., Nakagawa, S., Johnson, B. G., Cha, J. J., Mittelsteadt, K., Guckian, K. M., Gomez, I. G., Altemeier, W. A., & Duffield, J. S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87532 · Cited by 151
Saito, M. K., Nishikomori, R., Kambe, N., Fujisawa, A., Tanizaki, H., Takeichi, K., Imagawa, T., Iehara, T., Takada, H., Matsubayashi, T., et al. (2007) · Blood · doi:10.1182/blood-2007-06-094201 · Cited by 151
Inflammasomes in Intestinal Inflammation and Cancer
Chen, G., & Núñez, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.002 · Cited by 158
Pattern‐recognition receptors in human eosinophils
Kvarnhammar, A. M., & Cardell, L. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03556.x · Cited by 160
Müller, K. H., Motskin, M., Philpott, A. J., Routh, A. F., Shanahan, C. M., Duer, M. J., & Skepper, J. N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.041 · Cited by 152
Sun, Y., Zhao, Y., Yao, J., Zhao, L., Wu, Z., Wang, Y., Pan, D., Miao, H., Guo, Q., & Lu, N. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.002 · Cited by 150
Drexler, S. K., Bonsignore, L., Masin, M., Tardivel, A., Jackstadt, R., Hermeking, H., Schneider, P., Groß, O., Tschopp, J., & Yazdi, A. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209171109 · Cited by 154
Self-citationA2E Induces IL-1ß Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome
Anderson, O. A., Finkelstein, A., & Shima, D. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067263 · Cited by 152
Johnson, R. J., Lanaspa, M. A., & Gaucher, E. A. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.002 · Cited by 151
Li, X., Thome, S., Ma, X., Amrute‐Nayak, M., Finigan, A. J., Kitt, L., Masters, L. M., James, J. R., Shi, Y., Meng, G., et al. (2017) · Nature Communications · doi:10.1038/ncomms15986 · Cited by 160
Libby, P. (2021) · Cells · doi:10.3390/cells10040951 · Cited by 158
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Wang, Z., Li, Y., Liao, W., Huang, J., Liu, Y., Li, Z., & Tang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935723 · Cited by 154
Toll-like receptors and immune regulation: implications for cancer therapy
Wang, R.-F., Miyahara, Y., & Wang, H. Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210906 · Cited by 151
Toll or Toll-Free Adjuvant Path Toward the Optimal Vaccine Development
Ishii, K. J., & Akira, S. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9087-x · Cited by 149
Lin, Y., Huang, D.-Y., Wang, J.-S., Lin, Y., Hsieh, S.-L. E., Huang, K., & Lin, W. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0814-371rr · Cited by 148
Control of infection by pyroptosis and autophagy: role of TLR and NLR
Bortoluci, K. R., & Medzhitov, R. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0335-5 · Cited by 150
Torres, R., Macdonald, L. E., Croll, S. D., Reinhardt, J., Dore, A. T., Stevens, S. G., Hylton, D., Rudge, J. S., Liu‐Bryan, R., Terkeltaub, R. A., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.109355 · Cited by 148
NLRP3 recruitment by NLRC4 during Salmonella infection
Qu, Y., Misaghi, S., Newton, K., Maltzman, A., Izrael-Tomasevic, A., Arnott, D. P., & Dixit, V. M. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20132234 · Cited by 148
Mulay, S. R., & Anders, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1601611 · Cited by 154
Cartilage calcification in osteoarthritis: mechanisms and clinical relevance
Bernabei, I., So, A. K.-L., Busso, N., & Nasi, S. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00875-4 · Cited by 150
Abais, J. M., Zhang, C., Xia, M., Liu, Q., Gehr, T. W. B., Boini, K. M., & Li, P. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4666 · Cited by 148
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance
Dhodapkar, M. V., Dhodapkar, K. M., & Palucka, A. K. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402247 · Cited by 154
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
Boyapati, R. K., Rossi, A. G., Satsangi, J., & Ho, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.14 · Cited by 150
Maruzuru, Y., Ichinohe, T., Sato, R., Miyake, K., Okano, T., Suzuki, T., Koshiba, T., Koyanagi, N., Tsuda, S., Watanabe, M., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.014 · Cited by 150
Zhang, X., Xu, A., Lv, J., Zhang, Q., Ran, Y., Wei, C., & Wu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111822 · Cited by 148
Sellmayr, M., Petzsche, M. R. H., Ma, Q., Krüger, N., Liapis, H., Brink, A., Lenz, B. F., Angelotti, M. L., Gnemmi, V., Kuppe, C., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040523 · Cited by 147
Innate recognition of intracellular bacteria
Delbridge, L. M., & O’Riordan, M. X. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.11.005 · Cited by 147
Yilmaz, Ö., Sater, A. A. A., Yao, L., Koutouzis, T., Pettengill, M. A., & Ojcius, D. M. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01390.x · Cited by 146
Articular cartilage calcification in osteoarthritis: Insights into crystal‐induced stress
Ea, H., Nguyen, C., Bazin, D. C., Bianchi, A., Guicheux, J., Reboul, P., Daudon, M., & Lioté, F. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27761 · Cited by 146
Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra
McGonagle, D. G., Tan, A. L., Shankaranarayana, S., Madden, J. M., Emery, P., & McDermott, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073759 · Cited by 146
Marques-da-Silva, C., Chaves, M. M., Castro, N. G., Coutinho‐Silva, R., & Guimaraes, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01254.x · Cited by 145
Sensors of the innate immune system: their mode of action
Baccalà, R., González‐Quintial, R., Lawson, B. R., Stern, M. E., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.136 · Cited by 145
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 145
Nile, S. H., Ko, E. Y., Kim, D. H., & Keum, Y. (2015) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2015.08.013 · Cited by 145
Therapeutic approaches in the treatment of gout
Pillinger, M. H., & Mandell, B. F. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.010 · Cited by 153
Lv, D., Cao, X., Li, Z. A., Dong, Y., Xu, Z., Rong, Y., Xu, H., Wang, Z., Yang, H., Yin, R. H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101129 · Cited by 149
MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3
Pan, Q., Mathison, J. C., Fearns, C., Kravchenko, V. V., Correia, J. D. S., Hoffman, H. M., Kobayashi, K. S., Bertin, J., Grant, E. P., Coyle, A. J., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006627 · Cited by 145
Gout: new insights into an old disease
Martinon, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29404 · Cited by 145
Self-citationNLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens
Yao, Y., Wang, Y., Chen, F., Huang, Y., Zhu, S., Leng, Q., Wang, H., Shi, Y., & Qian, Y. (2012) · Cell Research · doi:10.1038/cr.2012.56 · Cited by 145
miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock
Xue, Z., Xi, Q., Liu, H., Guo, X., Zhang, J., Zhang, Z., Li, Y., Yang, G., Zhou, D., Yang, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1713-z · Cited by 147
Simpson, D. S., Pang, J., Weir, A. L., Kong, I. Y., Fritsch, M., Rashidi, M., Cooney, J. P., Davidson, K. C., Speir, M., Djajawi, T. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.003 · Cited by 146
AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity
Di Micco, A., Frera, G., Lugrin, J., Jamilloux, Y., Hsu, E.-T., Tardivel, A., De Gassart, A., Zaffalon, L., Bujisic, B., Siegert, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602419113 · Cited by 143
Self-citationBerthet, J., Damien, P., Hamzeh‐Cognasse, H., Arthaud, C., Eyraud, M., Zéni, F., Pozzetto, B., McNicol, A., Garraud, O., & Cognasse, F. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.09.004 · Cited by 143
Progress in understanding adjuvant immunotoxicity mechanisms
Batista-Duharte, A., Lindblad, E. B., & Oviedo‐Orta, E. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.03.001 · Cited by 143
Neutrophils, IL-1β, and gout: is there a link?
Mitroulis, I., Kambas, K., & Ritis, K. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0361-0 · Cited by 146
Frey, B., Rubner, Y., Wunderlich, R., Weiss, E., Pockley, A. G., Fietkau, R., & Gaipl, U. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800099811 · Cited by 149
Autoinflammatory Diseases: Clinical and Genetic Advances
Farasat, S., Aksentijevich, I. A., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.392 · Cited by 143
Vitamin B6 Prevents IL-1β Protein Production by Inhibiting NLRP3 Inflammasome Activation
Zhang, P., Tsuchiya, K., Kinoshita, T., Kushiyama, H., Suidasari, S., Hatakeyama, M., Imura, H., Katô, N., & Suda, T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.743815 · Cited by 146
IL-1 in osteoarthritis: time for a critical review of the literature
Vincent, T. L. (2019) · F1000Research · doi:10.12688/f1000research.18831.1 · Cited by 146
Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90
Xu, G., Fu, S., Zhan, X., Wang, Z., Zhang, P., Shi, W., Qin, N., Chen, Y., Wang, C., Niu, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134601 · Cited by 143
Blocking interleukin-1β in acute and chronic autoinflammatory diseases
Dinarello, C. A. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02313.x · Cited by 146
Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
Olive, C. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.189 · Cited by 152
Kim, M. L., Chae, J. J., Park, Y. H., Nardo, D. D., Stirzaker, R. A., Ko, H., Tye, H., Cengia, L. H., DiRago, L., Metcalf, D., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142384 · Cited by 147
Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages
Sandberg, W. J., Låg, M., Holme, J. A., Friede, B., Gualtieri, M., Kruszewski, M. K., Schwarze, P. E., Skuland, T., & Refsnes, M. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-32 · Cited by 145
NLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 144
Zhou, C., & Fang, J. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.001 · Cited by 143
Chu, J., Thomas, L. M., Watkins, S. C., Franchi, L., Núñez, G., & Salter, R. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309164 · Cited by 142
Toma, C., Higa, N., Koizumi, Y., Nakasone, N., Ogura, Y., McCoy, A. J., Franchi, L., Uematsu, S., Sagara, J., Taniguchi, S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903536 · Cited by 145
Self-citationPotential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
Fenini, G., Contassot, E., & French, L. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00278 · Cited by 147
Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook
Ashimova, A., Yegorov, S., Negmetzhanov, B., & Hortelano, G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00380 · Cited by 144
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor
Chen, Y., He, H., Lin, B., Chen, Y., Deng, X., Jiang, W., & Zhou, R. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00683-y · Cited by 142
Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment
Jung, E., Romero, R. J., Suksai, M., Gotsch, F., Chaemsaithong, P., Erez, O., Conde‐Agudelo, A., Gomez‐Lopez, N., Berry, S. M., Meyyazhagan, A., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.02.002 · Cited by 148
Hershfield, M. S., Roberts, L. J., Ganson, N. J., Kelly, S. J., Santisteban, I., Scarlett, E., Jaggers, D. A., & Sundy, J. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001072107 · Cited by 141
Mulla, M. J., Myrtolli, K., Potter, J. A., Boeras, C. M., Kavathas, P., Sfakianaki, A. K., Tadesse, S., Norwitz, E. R., Guller, S. M., & Abrahams, V. M. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00960.x · Cited by 141
Yang, M., Flavin, K., Kopf, I., Radics, G., Hearnden, C. H. A., McManus, G., Moran, B., Villalta‐Cerdas, A., Echegoyen, L. A., Giordani, S., et al. (2013) · Small · doi:10.1002/smll.201300481 · Cited by 142
Katsnelson, M. A., Lozada‐Soto, K. M., Russo, H. M., Miller, B. A., & Dubyak, G. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00298.2015 · Cited by 141
Inhibiting the Inflammasome: A Chemical Perspective
Baldwin, A. G., Brough, D., & Freeman, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01091 · Cited by 142
Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
Archer, M., Dogra, N., & Kyprianou, N. (2020) · Cancers · doi:10.3390/cancers12102984 · Cited by 144
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3
Cai, B., Zhao, J., Zhang, Y., Liu, Y., Ma, C., Yi, F., Zheng, Y., Zhang, L., Chen, T., Liu, H., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1965426 · Cited by 140
Metadata
- Authors
- Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J.
- Affiliations
- University of Lausanne (CH)
- Corresponding author
- Tschopp, Jürg
- Venue
- Nature
- Published
- 2006-01-11
- Volume
- 440
- Issue
- 7081
- Pages
- 237-241
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2009800174
- Cited by
- 5,326
- References
- 31
- Citations by year
- 2026: 227 · 2025: 246 · 2024: 305 · 2023: 310 · 2022: 333 · 2021: 335 · 2020: 340 · 2019: 297 · 2018: 280 · 2017: 248 · 2016: 287 · 2015: 290 · 2014: 271 · 2013: 299 · 2012: 238
- FWCI
- 76.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, NLRP3, gout, urate crystals, monosodium urate, calcium pyrophosphate dihydrate, pseudogout, caspase-1, IL-1β, IL-18, autoinflammatory disease, innate immunity, crystal-induced inflammation, neutrophil influx, IL-1 receptor, macrophages
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Calcium Pyrophosphate, Carrier Proteins, Cell Line, Cells, Cultured, Chondrocalcinosis, Colchicine, Disease Models, Animal, Gout, Humans, Inflammation, Interleukin-1, Macrophages, Neutrophils, Peritonitis, Uric Acid, Receptors, Interleukin-1, Caspase 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
